Transvaginal Ultrasonography Guided Embryo Transfer
Could Transvaginal Ultrasonography Guided Embryo Transfer Improves Pregnancy Outcome in Obese Patients Undergoing Intracytoplasmic Sperm Inoculation? Randomized Controlled Study
1 other identifier
interventional
800
1 country
1
Brief Summary
to evaluate the value of using transvaginal ultrasound guided embryo transfer in obese patients undergoing in vitro fertilization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2018
CompletedFirst Posted
Study publicly available on registry
March 21, 2018
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 4, 2021
CompletedApril 8, 2021
April 1, 2021
2.9 years
March 15, 2018
April 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical pregnancy rate'
the presence of at least one intrauterine gestational sac with viable fetus.
4 weeks following embryo transfer
Secondary Outcomes (1)
live birth rate
immediately following delivery
Study Arms (2)
transabdominal ultrasound
ACTIVE COMPARATOR400 obese female undergo transabdominal ultrasound guided embryo transfer
transvaginal group
ACTIVE COMPARATOR400 obese female undergo transvaginal ultrasound guided embryo transfer
Interventions
400 female with body mass index more than 30undergo transabdominal ultrasound guided embryo transfer
400 female with body mass index more than 30 undergo transvaginal ultrasound guided embryo transfer
Eligibility Criteria
You may qualify if:
- BMI more than 35, good ovarian reserve, unexplained infertility more than 3 years.
You may not qualify if:
- severe male factor of infertility,uterine factor of infertility excluded by ultrasonography and hysteroscopy ,ovarian endometrioma or patients with poly cystic ovary syndrome, obesity caused by abnormal endocrine function (thyroid or adrenal disorder)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kasr El Ainiy Hospital
Cairo, 11562, Egypt
Related Publications (1)
Mohamed Hassan S, Ramadan W, Elsharkawy M, Ali Bayoumi Y. The Role of Transvaginal Ultrasound Guided Embryo Transfer to Improve Pregnancy Rate in Obese Patients Undergoing Intracytoplasmic Sperm Injection. Int J Womens Health. 2021 Sep 21;13:861-867. doi: 10.2147/IJWH.S325557. eCollection 2021.
PMID: 34584462DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of obstetrics and gynecology
Study Record Dates
First Submitted
March 15, 2018
First Posted
March 21, 2018
Study Start
April 1, 2018
Primary Completion
February 18, 2021
Study Completion
March 4, 2021
Last Updated
April 8, 2021
Record last verified: 2021-04